A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods
NCT ID: NCT07211061
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
69 participants
INTERVENTIONAL
2011-09-21
2011-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Assess Clinical Gingivitis and Microbiome Following the Use of Multiple Oral Hygiene Products
NCT02401360
A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices
NCT06140784
To Investigate the Clinical Efficacy of an Experimental Toothpaste
NCT01079910
A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices
NCT06140771
Clinical Research Study to Assess the Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis.
NCT06244303
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Hygiene Regimen
toothpaste, electric toothbrush, and mouth rinse
Stannous Fluoride Dentifrice
brush 2x a day in using a power brush (2 minutes of brushing)
electric toothbrush
brush using a electric brush (2 minutes of brushing)
Cetylpyridinium Chloride (CPC)
use 20 ml of mouth rinse for 30 seconds
Negative Control
toothpaste and manual toothbrush
Sodium Fluoride Dentifrice
brush in their customary manner
manual toothbrush
brush in their customary manner
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stannous Fluoride Dentifrice
brush 2x a day in using a power brush (2 minutes of brushing)
Sodium Fluoride Dentifrice
brush in their customary manner
electric toothbrush
brush using a electric brush (2 minutes of brushing)
Cetylpyridinium Chloride (CPC)
use 20 ml of mouth rinse for 30 seconds
manual toothbrush
brush in their customary manner
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be 18 years of age or older;
* Agree not to participate in any other oral/dental product studies during the course of this study;
* Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed;
* Agree to refrain from any form of non-specified oral hygiene during the treatment periods, including but not limited to the use of products such as floss or whitening products;
* Have a Baseline MGI score of at least 1.75 but not greater than 2.3;
* Have at least 20 bleeding sites (sites with a score of 1 or 2 on the GBI index);
* Agree to return for all scheduled visits and follow study procedures;
* Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study.
Exclusion Criteria
* Have taken antibiotics or used anti-gingivitis / anti-bacterial oral care products such as chlorhexidine or Listerine within 2 weeks of plaque sampling visits;
* Have rampant caries, open or untreated caries, severe gingivitis, or advanced periodontitis requiring prompt treatment; or,
* Need an antibiotic prophylaxis prior to dental visits,
* Present with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study,
* Are pregnant (Self-reported) or lactating.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Procter and Gamble
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bio-Sci Research (Out of Business)
Las Vegas, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.